| __timestamp | Amphastar Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 759285000 |
| Thursday, January 1, 2015 | 251519000 | 862944000 |
| Friday, January 1, 2016 | 255165000 | 950751000 |
| Sunday, January 1, 2017 | 240175000 | 879387000 |
| Monday, January 1, 2018 | 294666000 | 661913000 |
| Tuesday, January 1, 2019 | 322357000 | 669893000 |
| Wednesday, January 1, 2020 | 349846000 | 644769000 |
| Friday, January 1, 2021 | 437768000 | 548970000 |
| Saturday, January 1, 2022 | 498987000 | 561347000 |
| Sunday, January 1, 2023 | 644395000 | 572952000 |
| Monday, January 1, 2024 | 629182000 |
Data in motion
In the competitive landscape of pharmaceuticals, Amphastar Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have showcased intriguing revenue trajectories over the past decade. From 2014 to 2023, Amphastar's revenue surged by over 200%, peaking in 2023 with a remarkable 644 million USD. In contrast, Taro's revenue, while initially higher, experienced a gradual decline, dropping by approximately 24% from its 2016 peak of 951 million USD to 573 million USD in 2023.
This divergence highlights Amphastar's robust growth strategy, possibly driven by innovative product lines and strategic market expansions. Meanwhile, Taro's revenue fluctuations suggest challenges in maintaining its market dominance. The data for 2024 remains incomplete, leaving room for speculation on future trends. As these companies navigate the ever-evolving pharmaceutical industry, their financial performances offer valuable insights into their strategic directions and market adaptability.
Revenue Showdown: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Annual Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amphastar Pharmaceuticals, Inc.
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Genmab A/S and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Incyte Corporation or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Arrowhead Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Amphastar Pharmaceuticals, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Taro Pharmaceutical Industries Ltd. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs BioCryst Pharmaceuticals, Inc.